Altered peptide ligands of islet autoantigen imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes

Journal of Autoimmunity

Volumn 11, Issue 4, 1998, Pages 353-361

  Geluk, Annemieke ^a   Van Meijgaarden, Krista E ^b   Roep, Bart O ^b   Ottenhoff, Tom H M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

APL; IDDM; Imogen 38

Indexed keywords

AUTOANTIGEN; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031754261     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0207     Document Type: Article

References (42)

1. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. 1983. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339
2. Baekkeskov S., Aanstoot H-J., Christgau S., Raetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., DeCamilli P. 1990. Identification of the 64K auytoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
3. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S. 1991. Identification and cloning of a granule autoantigen (carboxypeptidaseH) associated with type 1 diabetes. J. Clin. Endocrinol. & Metab. 73: 1197-1201
4. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y.L.S., Martin S., Martin A., Powers A.C., Prochazka M., Naggert J., Leiter E.H., Eisenbarth G.S. 1993. Islet cell autoantigen 69kDa (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest. 92: 359-371
5. Payton M.A., Hawkes C.J., Christie M.R. 1995. Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96: 1506-1511
6. Bendelac A.C., Carnaud C., Boitard C., Bach J.-E 1987. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. J. Exp. Med. 166: 823-832
7. Roep B.O. 1996. T cell responses to autoantigens in IDDM. The search for the holy grail. Diabetes 45: 1147-1156
8. Haskins K., Wegmann D. 1996. Diabetogenic T cell clones. Diabetes 45: 1299-1305
9. Atkinson M.A., Kaufman D.L., Cambell L., Gibbs K.A., Shah S.C., Bu D.-F., Erlander M.G., Tobin A.J., Maclaren N.K. 1992. Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459
10. Roep B.O., Arden S.D., de Vries R.R.P., Hutton J.C. 1990. T cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345: 632-634
11. Arden S.D., Roep B.O., Neophytou P.I., Usac E.F., Duinkerken G., de Vries R.R.P., Hutton J.C. 1996. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest. 97: 551-561
12. Roep B.O., Kallan A.A., Duinkerken G., Arden S.D., Hutton J.C., Bruining G.J., de Vries R.R.P. 1995. T cell reactivity to β cell destruction in IDDM. Diabetes 44: 278-283
13. Roep B.O., Kallan A.A., Hazenbos W.L.W., Bruining G.J., Bailyes E.M., Arden S.D., Hutton J.C., de Vries R.R.P. 1990. T cell reactivity to 38 kDa insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337: 1439-1441
14. Van Vliet E., Roep B.O., Meulenbroek L., Bruining G.J., de Vries R.R.P. 1989. Human T cell clones with specificity for insulinoma cell antigens. Eur. J. Immunol. 19: 213-216
15. Neophytou P.I., Roep B.O., Arden S.D., Muir E.M., Duinkerken G., Kallan A.A., de Vries R.R.P., Hutton J.C. 1996. T cell epitope analysis using subtracted expression libraries (TEASEL): Application to a 38 kDa autoantigen recognized by T cells from an insulin-dependent diabetic patient. Proc. Natl. Acad. Sci. USA 93: 2014-2018
16. Wauben M.H.M., Hoedmaekers A.C.W.E., Graus Y.M.F., Wagenaar J.P.A., van Eden W., de Baets M.H. 1996. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response. Eur. J. Immunol. 26: 2866-2875
17. Hurtenbach U., Lier E., Adorini L., Nagy Z. 1993. Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J. Exp. Med. 177: 1499-1504
18. Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., auMartin R., Utz U., Karin N., Mitchell D., Veromaa T., Waisman A., Gaur A., Conion P., Ling N., Fairchild P.J., Wraith D.C., O'Garra A., Fathman C.G., Steinman L. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379: 343-346
19. Sette A., Alexander J., Ruppert I., Snoke K., Franco A., Ishioka G., Grey H.M. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12: 413-431
20. Zisman E., Katz-Levy Y., Dayan M., Kirshner S.L., Paas-Rozner M., Kami A., Abramsky O., Brautbar C., Fridkin M., auSela M., Mozes E. 1996. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor a subunit as potential modulators of myasthenia gravis. Proc. Natl. Acad. Sci. USA 93: 4492-4497
21. Sloan-Lancaster I., Evavold B.D., Allen P.M. 1993. Induction of T cell anergy by altered T cell receptor ligand on live antigen-presenting cells. Nature 363: 156-159
22. Evavold B.D., Allen P.M. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252: 1308-1310
23. Chaturvedi P., Yu Q., Southwood S., Sette A., Singh B. 1996. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int. Immunol. 8: 745-755
24. Windhagen A., Scholz C., Hollsberg P., Fukaura H., Sette A., Hafler D.A. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2: 373-380
25. Karin N., Mitchell D.J., Brocke S., Ling N., Steinman L. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of IFN-γ and TNF-α production. J. Exp. Med. 180: 2227-2237
26. Tao X., Grant C., Constant S., Bottomly K. 1997. Induction of IL-4-preducing CD4+ T cells by antigenic peptides altered for TCR binding. J. Immunol. 158: 4237-4244
27. De Magistris M.T., Alexander J., Coggeshall M., Altman A., Gaeta F.C.A., Grey H.M., Sette A. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68: 625-634
28. Sloan-Lancaster J., Allen P.M. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14: 1-27
29. Bertoletti A., Sette A., Chisari F.V., Penna A., Levrero M., De Carli M., auFiaccadori F., Ferrari C. 1994. Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells. Nature 369: 407-410
30. Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Köppe B., Rosenberg W., Boyd D., Edwards A., Giangrande P., Phillips R.E., McMichael A.J. 1994. Cytotoxic T cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369: 403-407
31. Geluk A., van Meijgaarden K.E., Drijfhout J., Ottenhoff T.H.M. 1995. CLIP binds to HLA class II using methionine based, allele dependent motifs as well as allele independent supermotifs. Mol. Immunol. 32: 975-981
32. Hammer J., Takacs B., Sinigaglia F. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176: 1007-1013
33. Tsitoura D.C., Holter W., Cerwenka A., Gelder C.M., Lamb J.R. 1996. Induction of anergy in human T helper O cells by stimulation with altered T cell antigen receptor ligands. J. Immunol. 156: 2801-2808
34. Minami Y., Samelson L.E., Klausner R.D. 1987. Internalization and cycling of the T cell antigen receptor. J. Biol. Chem. 262: 13342-13347
35. Lopez-Cabrera M., Santis A.G., Fernandez-Ruiz E., Blacher R., Esch F., Sanchez-Mateos P., Sanchez-Madrid F. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178: 537-547
36. La Face D.M., Couture C., Anderson K., Shih G., Alexander J., Sette A., Mustelin T., Altman A., Grey H.M. 1997. Differential T cell signalling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J. Immunol. 158: 2057-2064
37. Jameson S.C., Bevan M.J. 1995. T cell receptor antagonists and partial agonists. Immunity 2: 1-11
38. Nicholson L.B., Greer J.M., Sobel R.A., Kuchroo V.K. 1995. An altered peptide-ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3: 397-405
39. Hultgren B., Huang X., Dybdal N., Stewart T.A. 1996. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45: 812-817
40. Rabinowitz J.D., Beeson C., Lyons D.S., Davis M.M., McConnell H.M. 1996. Kinetic discrimination in T cell activation. Proc. Natl. Acad. Sci. USA 93: 1401-1405
41. Alam S.M., Travers P.J., Wung J.L., Nasholds W., Redpath S., Jameson S.C., Gascoigne N.R.J. 1996. T cell receptor affinity and thymocyte positive selection. Nature 381: 616-620
42. Lyons D.S., Lieberman S.A., Hampl J., Boniface J.J., Chien Y., Berg L.J., Davis M.M. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5: 53-61